Fortitude Family Office, LLC Neurocrine Biosciences Inc Transaction History
Fortitude Family Office, LLC
- $280 Billion
- Q4 2024
A detailed history of Fortitude Family Office, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Fortitude Family Office, LLC holds 6 shares of NBIX stock, worth $696. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6
Previous 17
64.71%
Holding current value
$696
Previous $1.96 Million
58.19%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NBIX
# of Institutions
654Shares Held
96.5MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.65 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.17 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$568 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$350 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$295 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...